In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.41.8.1835PMID 9257774PMCID PMC164018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi

  1996influential reference
• Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

  1995cited by this paper
• Fungal infections in the immunocompromised host.

  1984cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Three decades of pneumocandin research: Derivatives, structural insights, and strain engineering

  2026cites this paper
• Combatting Fungal Infections: Advances in Antifungal Polymeric Nanomaterials.

  2024cites this paper
• Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review

  2023cites this paper
• Serine/Threonine Phosphatase Calcineurin Orchestrates the Intrinsic Resistance to Micafungin in the Human-Pathogenic Fungus Mucor circinelloides

  2023cites this paper
• Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents

  2022cites this paper
• The emerging role of computational design in peptide macrocycle drug discovery

  2020cites this paper
• Management of phaeohyphomycosis

  2019cites this paper
• Invasive Mucormycosis Causing Rhino-orbital Cellulitis

  2019cites this paper
• Management and Novel Adjuncts of Necrotizing Soft Tissue Infections

  2017cites this paper
• Echinocandins in antifungal pharmacotherapy

  2017influential citation
• Echinocandins in Ocular Therapeutics

  2017cites this paper
• Identificação e caracterização de proteínas imunogênicas de exoantígenos do fungo Fonsecaea pedrosoi

  2015cites this paper
• Clinical Importance of the Genus Curvularia

  2015cites this paper
• Black Molds and Melanized Yeasts Pathogenic to Humans.

  2015cites this paper
• Agents of Chromoblastomycosis

  2015cites this paper
• ANTIFUNGAL SCREENING OF 61 TRADITIONAL MEDICINAL PLANTS OF 305 EXTRACTS AGAINST DERMATOPHYTIC FUNGI TRICHOPHYTON TONSURANS

  2015cites this paper
• Combination Therapy for the Treatment of Mucormycosis: Examining the Evidence

  2015cites this paper
• Mucormycosis in a Renal Transplant Recipient: Case Report and Comprehensive Review of Literature

  2014cites this paper
• Fusarium Keratitis: Genotyping, In Vitro Susceptibility and Clinical Outcomes

  2013cites this paper
• A Case of Alternaria Rhinosinusitis in a Patient with Myelodysplastic Syndrome during Neutropenic Period

  2012cites this paper
• Caspofungin

  2012cites this paper
• Newer Systemic Antifungal Agents

  2012cites this paper
• Caspofungin

  2012cites this paper
• Purpureocillium lilacinum as a Cause of Cavitary Pulmonary Disease: a New Clinical Presentation and Observations on Atypical Morphologic Characteristics of the Isolate

  2012cites this paper
• The Cell Wall of Cryptococcus

  2011cites this paper
• Phaeohyphomycoses (Brown-Black Moulds)

  2011cites this paper
• Hyalohyphomycoses (Hyaline Moulds)

  2011cites this paper
• Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.

  2011cites this paper
• Exophiala jeanselmei infection in solid organ transplant recipients: report of two cases and review of the literature

  2011cites this paper
• Current Controversies in the Treatment of Fungal Infections

  2011cites this paper
• Resistance to Antifungal Agents

  2010cites this paper
• Uncommon Fungi and Prototheca

  2010cites this paper
• Necrotizing soft tissue infections in the intensive care unit

  2010cites this paper
• Mucormycosis, pseudallescheriasis, and other uncommon mold infections.

  2010cites this paper
• Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.

  2009cites this paper
• Alternaria Keratitis: Clinical Presentation and Resolution With Topical Fluconazole or Intrastromal Voriconazole and Topical Caspofungin

  2009cites this paper
• Right buttock rash for thirty years in a patient from China.

  2009cites this paper
• Echinocandins for prevention and treatment of invasive fungal infections

  2009cites this paper
• Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.

  2009cites this paper
• CHAPTER 27 – Fungal infections of the respiratory tract

  2009cites this paper
• Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.

  2009cites this paper
• Phaeohyphomycosis due to Alternaria species in transplant recipients

  2009cites this paper
• Current status of newer antiinfectives.

  2008cites this paper
• Combination Echinocandin-Polyene Treatment of Murine Mucormycosis

  2008cites this paper
• Susceptibility Testing and Molecular Classification of Paecilomyces spp

  2008cites this paper
• Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

  2008cites this paper
• Alternaria infections: laboratory diagnosis and relevant clinical features.

  2008cites this paper
• Resistance to Antifungal Agents: Mechanisms and Clinical Impact

  2008cites this paper
• A review of clinical experience with newer antifungals in children.

  2008cites this paper
• Infections Caused by Scedosporium spp

  2008cites this paper
• Chapter 53 – Antifungal and Antiviral Therapy

  2008cites this paper
• Nosocomial fungal infections: epidemiology, diagnosis, and treatment.

  2007cites this paper
• Biological evaluation of neopeptins isolated from a Streptomyces strain.

  2007cites this paper
• Caspofungine et mycoses à champignons rares : activité in vitro et in vivo chez l’animal et chez l’homme

  2007cites this paper
• Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.

  2007cites this paper
• Fungal infections in primary immunodeficiencies

  2007cites this paper
• Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.

  2007cites this paper
• Hospital-acquired phaeohyphomycosis due to Exserohilum rostratum in a child with leukemia.

  2007cites this paper
• Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.

  2007cites this paper
• Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.

  2007cites this paper
• Echinocandins in the management of invasive fungal infections, part 1.

  2006cites this paper
• Fungal Pneumonia Due to Molds in Patients with Hematological Malignancies

  2006cites this paper
• Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

  2006cites this paper
• Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

  2006cites this paper
• Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

  2006cites this paper
• Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

  2006cites this paper
• Zygomycetes as agents of infectious disease in humans.

  2006cites this paper
• Caspofungin

  2006cites this paper
• New agents for invasive mycoses in children

  2005cites this paper
• Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.

  2005cites this paper
• In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.

  2005cites this paper
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

  2005cites this paper
• Combination Treatment of Invasive Fungal Infections

  2005cites this paper
• In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.

  2005cites this paper
• Management of Infection With Naturally Amphotericin B-Resistant Fungi

  2004cites this paper
• Infections due to emerging and uncommon medically important fungal pathogens.

  2004cites this paper
• Scedosporium/Pseudallescheria Infections

  2004cites this paper
• Recent advances in antifungal pharmacotherapy for invasive fungal infections

  2004cites this paper
• In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates

  2004cites this paper
• Bull's-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation.

  2004cites this paper
• Fusarium Infections in Critically Ill Patients

  2004cites this paper
• Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B

  2004cites this paper
• Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

  2004cites this paper
• Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

  2004cites this paper
• Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.

  2004cites this paper
• Fusarium infections in critically ill patients.

  2004cites this paper
• Mucormycosis in hematologic patients.

  2004cites this paper
• Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes

  2004cites this paper
• Scedosporium/Pseudallescheria infections.

  2004cites this paper
• Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery

  2003cites this paper
• Newer antifungal therapy for emerging fungal pathogens.

  2003cites this paper
• Antifungal pharmacotherapy for invasive mould infections

  2003cites this paper
• Caspofungin: the first representative of a new antifungal class.

  2003cites this paper
• Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide

  2003cites this paper
• Caspofungin Acetate for Treatment of Invasive Fungal Infections

  2003cites this paper
• What’s new in antifungals?

  2003cites this paper
• In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.

  2003cites this paper
• Scedosporium Species Infections and Treatments

  2003cites this paper
• The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function

  2003cites this paper
• Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)

  2003cites this paper